Significant differences when using creatinine, modification of diet in renal disease, or cystatin C for estimating glomerular filtration rate in ICU patients
2010

Comparing GFR Estimation Methods in ICU Patients

Sample size: 1838 publication 10 minutes Evidence: high

Author Information

Author(s): Miklós Lipcsey, Mia Furebring, Sten Rubertsson, Anders Larsson

Primary Institution: Uppsala University Hospital

Hypothesis

Is cystatin C a better marker for estimating glomerular filtration rate (GFR) than creatinine and MDRD in ICU patients?

Conclusion

Cystatin C-estimated GFR yields significantly lower results than plasma creatinine and MDRD, indicating that the choice of GFR estimation method can influence treatment decisions in ICU patients.

Supporting Evidence

  • 92% of patients had cystatin C-estimated GFR ≤ 80 mL/min/1.73 m2.
  • Only 46% of patients had reduced renal function assessed by plasma creatinine alone.
  • The mean difference between eGFRMDRD and eGFRcystatinC was 39 mL/min/1.73 m2 for eGFRcystatinC values ≤ 60 mL/min/1.73 m2.

Takeaway

Doctors use different tests to check how well kidneys are working. This study found that one test, called cystatin C, shows more kidney problems than the usual test, creatinine.

Methodology

Retrospective observational study of ICU patients from 2004 to 2006, comparing GFR estimates from creatinine, MDRD, and cystatin C.

Potential Biases

Potential bias in test results due to variations in patient demographics and health conditions.

Limitations

The study is retrospective and may not account for all variables affecting GFR estimation.

Participant Demographics

Patients treated in a general ICU, with a mean age of 62 years; 63% male and 37% female.

Statistical Information

P-Value

<0.0001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3109/03009734.2010.526724

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication